THL Credit, Inc.
TCRZ
New York Stock Exchange24.59
USD
+0.25
- -
Return %
Stock
S&P500
1Y
- -
26.84
3Y
-3.57
77.03
5Y
-4.65
80.55
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- IPO Date
- Dec 17, 2015
- Similar Companies
- Business
- THL Credit, Inc. (Ticker: TCRZ) is a specialty finance company that originates and invests in privately negotiated senior secured first lien term loans and mezzanine debt primarily to small and mid-sized U.S. companies with enterprise values between $20 million and $500 million. The company offers collateralized first lien senior secured loans, unitranche loans, second lien secured loans, and mezzanine investments; it also selectively provides equity co-investments alongside its debt financings. THL Credit targets lower middle-market companies across diverse industries including business services, healthcare, manufacturing, and consumer goods, with operations focused in the United States. Founded in 2007 and headquartered in Boston, Massachusetts, the company manages assets through its investment adviser, THL Credit Advisors LLC, and operates as a business development company under the Investment Company Act of 1940. It generates revenue through interest income, dividend income, and capital gains from portfolio investments, while employing a disciplined underwriting process to mitigate credit risk. In recent developments, THL Credit, Inc. completed a ticker symbol change to TCRZ in late 2024 to better reflect its strategic focus on credit opportunities amid market volatility. The company announced a new senior secured credit facility partnership with key institutional lenders in early 2025, enhancing its lending capacity by $150 million. Additionally, it launched an expanded mezzanine product offering targeting healthcare subsector expansions and completed the acquisition of a portfolio of unitranche loans from a distressed seller in Q3 2025, marking a significant operational scale-up.